Search

Your search keyword '"MD simulation"' showing total 5,226 results

Search Constraints

Start Over You searched for: Descriptor "MD simulation" Remove constraint Descriptor: "MD simulation"
5,226 results on '"MD simulation"'

Search Results

201. Synthesis, biological evaluation, molecular docking, MD simulation and DFT analysis of new 3-hydroxypyridine-4-one derivatives as anti-tyrosinase and antioxidant agents

202. Rational design and computational evaluation of a multi-epitope vaccine for monkeypox virus: Insights into binding stability and immunological memory

203. Exploring the mechanism of action of Vanda tessellata extract for the treatment of osteoarthritis through network pharmacology, molecular modelling and experimental assays

204. Differential conformational dynamics in two type-A RNA-binding domains drive the double-stranded RNA recognition and binding

205. Identification of 2-(N-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity

206. Identification of novel NLRP3 inhibitors as therapeutic options for epilepsy by machine learning-based virtual screening, molecular docking and biomolecular simulation studies

207. Virtual screening, molecular docking, MD simulation studies, DFT calculations, ADMET, and drug likeness of Diaza-adamantane as potential MAPKERK inhibitors

208. In silico evaluation of cis-dihydroxy-indeno[1,2-d]imidazolones as inhibitors of glycogen synthase kinase-3: synthesis, molecular docking, physicochemical data, ADMET,MD simulation, and DFT calculations

209. Solvation effects, structural, vibrational analysis, chemical reactivity, nanocages, ELF, LOL, docking and MD simulation on Sitagliptin

210. Simulation and experimental evaluation of laser-induced graphene on the cellulose and lignin substrates

211. TRIP-TWIP effect in deformation mechanisms of Co–Cr–Ni medium entropy via molecular dynamics simulations

214. Effect of HFO Refrigerants on Lubrication Characteristics (Part 2)

215. Repurposed drug molecules targeting NSP12 protein of SARS-CoV-2: An in-silico study

216. Dual Antimicrobial Activity of HTCC and Its Nanoparticles: A Synergistic Approach for Antibacterial and Antiviral Applications Through Combined In Silico and In Vitro Studies

217. Computational Screening of T-Muurolol for an Alternative Antibacterial Solution against Staphylococcus aureus Infections: An In Silico Approach for Phytochemical-Based Drug Discovery

227. Simulation and experimental evaluation of laser-induced graphene on the cellulose and lignin substrates.

228. Effect of azobenzene composition ratio on the degree of photosoftening: Experimental and molecular dynamics simulation studies.

229. Computational studies of Salvurmin A and Salvurmin B, two ursane triterpenoids of Salvia Urmiensis as anti-cancer agents: molecular docking, molecular dynamic simulation, and DFT and ADMET analysis.

230. Pharmacophore-based computational study on inhibitor of TMPRSS6 as hepcidin modulator in an iron overload of beta-thalassaemia.

231. Quality Control of Coumarins, Furocoumarins and Polymethoxyflavones in Citrus Essential Oils: In Silico Analysis.

232. Natural products from Streptomyces spp. as potential inhibitors of the major factors (holoRdRp and nsp13) for SARS-CoV-2 replication: an in silico approach.

233. Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor.

234. A comparative insight into peptide folding with quantum CVaR-VQE algorithm, MD simulations and structural alphabet analysis.

235. Unveiling the Antiviral Efficacy of Forskolin: A Multifaceted In Vitro and In Silico Approach.

236. Characterization of caffeic acid-induced changes in the structure and stability of lysozyme: insights from spectroscopy and molecular dynamics simulations.

237. Thermo-mechanical properties of silica-reinforced PLA nanocomposites using molecular dynamics: The effect of nanofiller radius.

238. An Adaptive Parallel Pattern Based Design for Molecular Dynamic Simulation.

239. Synthesis, biological application, and computational study of a thymol-based molecule.

240. S288T mutation altering MmpL3 periplasmic domain channel and H-bond network: a novel dual drug resistance mechanism.

241. Cyanobacterial metabolites as novel inhibitors of BACE1 implicated in Alzheimer's disease through in silico approaches.

242. Target-based virtual screening and molecular dynamics approach to identify potential antileishmanial agents through targeting UvrD-like helicase ATP-binding domain.

243. DFT, Fukui indices, and molecular dynamic simulation studies on corrosion inhibition characteristics: a review.

244. Therapeutic Potential of HMF and Its Derivatives: a Computational Study.

245. Atomistic Simulation of the Interaction between the Σ9[110](221) Shear-Coupled Grain Boundary Motion and the Cu-rich Precipitates in α-Iron.

246. Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response.

247. Structure-based virtual screening and molecular dynamics studies to explore potential natural inhibitors against 3C protease of foot-and-mouth disease virus.

248. Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system.

249. Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations.

250. Exploring the potential of fluoro‐flavonoid derivatives as anti‐lung cancer agents: DFT, molecular docking, and molecular dynamics techniques.

Catalog

Books, media, physical & digital resources